precision medicine

Dallas-Based Susan G. Komen Awards $10.8M in New Breast Cancer Research Grants

by | Jun 25, 2025
Funding 25 projects across 17 institutions, the Dallas-founded nonprofit is prioritizing metastatic disease, precision medicine, and closing care gaps.
MORE
Caris Life Sciences Appoints Chief Business Officer, Biopharma Business Development
by | May 8, 2025
Eric Matthews will provide strategic leadership to biopharma business development, and through his executive leadership, support Caris' expanding portfolio of biopharma partnerships, the company said.
MORE
Dr. David Spetzler
Caris Life Sciences Partners with Moderna To Advance mRNA-Based Cancer Drugs
by | Oct 24, 2023
Irving-based Caris said that via this multiyear agreement, Moderna will leverage Caris’ extensive library of de-identified, multimodal data solutions derived from whole exome sequencing, whole transcriptome sequencing, and protein analyses—along with claims data to improve development strategies for Moderna’s oncology pipeline.
MORE
Irving’s Caris Life Sciences Raises $830M to Grow Its Precision Medicine Platform for Cancer Care
by | May 12, 2021
Now valued at more than $7.8 billion, Caris specializes in AI-powered genetic sequencing for personalized cancer treatments. The massive capital raise follows a $310 million round in October and boosts the 13-year-old company's total funding to about $1.3 billion.
MORE
genome

North Texas Genome Center Seen as Boon for Health Care, DFW Economy

by | Mar 2, 2018
The new center, on the campus of UT Arlington, will be available to academic and corporate researchers. Official said it could help elevate the region as a leader in precision medicine.
MORE
health trends
5 Health Trends to Keep Your Eyes on in 2017
by | Jan 9, 2017
Artificial intelligence, emancipating role of health care consumers, and genetic testing are some of the trends to expect in 2017 Hubert Zajicek says.
MORE